Holocene Advisors, LP Abiomed Inc Transaction History

Holocene Advisors, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$300.63 - $371.35 $190,599 - $235,435	-634 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$310.19 - $376.2 $480,794 - $583,110	-1,550 Reduced 70.97%	634 $206,000
Q2 2021 Aug 16, 2021	SELL	$262.71 - $351.17 $278,209 - $371,889	-1,059 Reduced 32.65%	2,184 $682,000
Q1 2021 May 17, 2021	BUY	$285.92 - $355.13 $231,023 - $286,945	808 Added 33.18%	3,243 $1.03 Million
Q4 2020 Feb 16, 2021	BUY	$251.88 - $324.2 $613,327 - $789,427	2,435 New	2,435 $789,000
Q3 2020 Nov 16, 2020	SELL	$255.22 - $317.0 $502,528 - $624,173	-1,969 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$141.4 - $257.09 $278,416 - $506,210	1,969 New	1,969 $476,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on Holocene Advisors, LP with notifications on news.